Literature DB >> 8269860

ES cells have only a limited lymphopoietic potential after adoptive transfer into mouse recipients.

A M Müller1, E A Dzierzak.   

Abstract

While hematopoietic stem cells from adult and fetal stages of murine development are capable of long term reconstitution of all mature blood lineages in vivo, embryonic hematopoietic stem cell repopulation in vivo has proved difficult. It is thought that there are many fewer hematopoietic stem cells in the embryo than in the fetal/adult stages of mouse development and that these cells possess a different developmental potential. One source of such cells are embryonic stem (ES) cells which can differentiate into most mature blood lineages in vitro. We have therefore used transplantation of differentiated ES cells to assess the hematopoietic potential of embryonic hematopoietic cells in vivo. We demonstrate here that precursors obtained from in vitro cultures of normal ES cells can contribute only to restricted and limited hematopoiesis in a mouse without leading to tumour formation. Repopulation occurs for greater than 6.5 months at levels ranging from 0.1% to 6% in B and T cell lineages in peripheral blood. In contrast to in vitro colony data demonstrating the myeloid lineage developmental potential of ES cells, no donor-derived myeloid repopulation was observed in CFU-S assays and no macrophage and mast cells were found in long term repopulated recipients. Thus, the hematopoietic potential of ES cells in vivo is limited to low levels of repopulation and is restricted to the lymphoid lineage.

Entities:  

Mesh:

Year:  1993        PMID: 8269860     DOI: 10.1242/dev.118.4.1343

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  23 in total

Review 1.  Genesis of hematopoietic stem cells in vitro and in vivo: new insights into developmental maturation.

Authors:  Michael Kyba
Journal:  Int J Hematol       Date:  2005-05       Impact factor: 2.490

2.  Embryonic stem cells make human T cells.

Authors:  Heather E Fleming; David T Scadden
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-07       Impact factor: 11.205

3.  Surface antigen phenotypes of hematopoietic stem cells from embryos and murine embryonic stem cells.

Authors:  Shannon L McKinney-Freeman; Olaia Naveiras; Frank Yates; Sabine Loewer; Marsha Philitas; Matthew Curran; Peter J Park; George Q Daley
Journal:  Blood       Date:  2009-05-06       Impact factor: 22.113

4.  Induction of hematopoietic differentiation of mouse embryonic stem cells by an AGM-derived stromal cell line is not further enhanced by overexpression of HOXB4.

Authors:  Sabrina A M Gordon-Keylock; Melany Jackson; Caoxin Huang; Kay Samuel; Richard A Axton; Robert A J Oostendorp; Helen Taylor; Julie Wilson; Lesley M Forrester
Journal:  Stem Cells Dev       Date:  2010-09-09       Impact factor: 3.272

Review 5.  From marrow to matrix: novel gene and cell therapies for epidermolysis bullosa.

Authors:  Beau R Webber; Jakub Tolar
Journal:  Mol Ther       Date:  2015-03-24       Impact factor: 11.454

Review 6.  Making HSCs in vitro: don't forget the hemogenic endothelium.

Authors:  Bradley W Blaser; Leonard I Zon
Journal:  Blood       Date:  2018-08-08       Impact factor: 22.113

Review 7.  Lymphoid progenitor emergence in the murine embryo and yolk sac precedes stem cell detection.

Authors:  Yang Lin; Mervin C Yoder; Momoko Yoshimoto
Journal:  Stem Cells Dev       Date:  2014-02-18       Impact factor: 3.272

8.  Hemato-lymphoid in vivo reconstitution potential of subpopulations derived from in vitro differentiated embryonic stem cells.

Authors:  A J Potocnik; H Kohler; K Eichmann
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

Review 9.  De novo generation of HSCs from somatic and pluripotent stem cell sources.

Authors:  Linda T Vo; George Q Daley
Journal:  Blood       Date:  2015-03-11       Impact factor: 22.113

Review 10.  Bcr-Abl is a "molecular switch" for the decision for growth and differentiation in hematopoietic stem cells.

Authors:  Takumi Era
Journal:  Int J Hematol       Date:  2002-07       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.